[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][O][C][=N][N][C][=Branch2][Ring2][=Branch2][=C][Branch1][Branch1][C][=N][Ring1][Branch1][C][=N][C][=Branch1][=Branch1][=N][C][=C][Ring1][=Branch1][N][C][=C][C][=Branch1][S][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][Branch1][C][F][Branch1][C][F][F][O][C][C][=C][Ring2][Ring1][N]"}, {"from": "gpt", "value": "The molecule is a pyrazolopyridazine that is pyrazolo[1,5-b]pyridazine which is substituted by a 2-[3-methoxy-5-(trifluoromethyl)anilino]pyrimidin-4-yl group at position 3 and by a methoxy group at position 6. It is a human GSK-3beta, CDK2, CDK4, CLK1, CLK2, and CLK4 kinase inhibitor. It has a role as an EC 2.7.11.26 (tau-protein kinase) inhibitor, an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor and an EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor. It is a pyrazolopyridazine, an aromatic ether, a member of pyrimidines, a secondary amino compound, a substituted aniline, a monomethoxybenzene and a member of (trifluoromethyl)benzenes."}]